Poor outcome in Acute Myeloid Leukemia (AML) is associated with the elevated expression of P-glycoprotein (Pgp) and the Multidrug-Associated Resistance Protein (MRP1), members of the ATP-Binding Cassette (ABC) protein superfamily. However, a proportion of A M L patient blasts demonstrates drug-efflux that is not correlated with Pgp or MRP1 expression. The AML1, 2 and 3 cell lines, derived from AML patient blasts at relapse, exhibit ATP-dependent daunorubicin accumulation with no Pgp and low MRP1 expression. This evidence strongly suggests the presence of energy-dependent processes distinct from Pgp that contribute to daunorubicin efflux. The large number of human ABC proteins (>50) and the complex nature of drug efflux in Multiple D...
A major problem in the treatment of patients with acute myeloid leukemia (AXIL) is the occurrence of...
A major problem in the treatment of patients with acute myeloid leukemia (AXIL) is the occurrence of...
A major problem in the treatment of patients with acute myeloid leukemia (AXIL) is the occurrence of...
Multidrug resistance (MDR) in cancer is characterized by cross-resistance to a variety of structura...
Multidrug resistance (MDR) in cancer is characterized by cross-resistance to a variety of structura...
Multidrug resistance (MDR) is a major impediment to the successful treatment of acute myeloid leukem...
Multidrug resistance (MDR) is a major impediment to the successful treatment of acute myeloid leukem...
Multidrug resistance (MDR) is a major impediment to the successful treatment of acute myeloid leukem...
Hematopoietic cells express ATP binding cassette (ABC) transporters in relation to different degre...
Hematopoietic cells express ATP binding cassette (ABC) transporters in relation to different degre...
BACKGROUND AND OBJECTIVES: Relapse is common in acute myeloid leukemia (AML) because of persistence ...
BACKGROUND AND OBJECTIVES: Relapse is common in acute myeloid leukemia (AML) because of persistence ...
Multidrug Resistance (MDR), resistance to multiple chemotherapeutic drugs, is a major problem in th...
A major problem in the treatment of patients with acute myeloid leukemia (AXIL) is the occurrence of...
A major problem in the treatment of patients with acute myeloid leukemia (AXIL) is the occurrence of...
A major problem in the treatment of patients with acute myeloid leukemia (AXIL) is the occurrence of...
A major problem in the treatment of patients with acute myeloid leukemia (AXIL) is the occurrence of...
A major problem in the treatment of patients with acute myeloid leukemia (AXIL) is the occurrence of...
Multidrug resistance (MDR) in cancer is characterized by cross-resistance to a variety of structura...
Multidrug resistance (MDR) in cancer is characterized by cross-resistance to a variety of structura...
Multidrug resistance (MDR) is a major impediment to the successful treatment of acute myeloid leukem...
Multidrug resistance (MDR) is a major impediment to the successful treatment of acute myeloid leukem...
Multidrug resistance (MDR) is a major impediment to the successful treatment of acute myeloid leukem...
Hematopoietic cells express ATP binding cassette (ABC) transporters in relation to different degre...
Hematopoietic cells express ATP binding cassette (ABC) transporters in relation to different degre...
BACKGROUND AND OBJECTIVES: Relapse is common in acute myeloid leukemia (AML) because of persistence ...
BACKGROUND AND OBJECTIVES: Relapse is common in acute myeloid leukemia (AML) because of persistence ...
Multidrug Resistance (MDR), resistance to multiple chemotherapeutic drugs, is a major problem in th...
A major problem in the treatment of patients with acute myeloid leukemia (AXIL) is the occurrence of...
A major problem in the treatment of patients with acute myeloid leukemia (AXIL) is the occurrence of...
A major problem in the treatment of patients with acute myeloid leukemia (AXIL) is the occurrence of...
A major problem in the treatment of patients with acute myeloid leukemia (AXIL) is the occurrence of...
A major problem in the treatment of patients with acute myeloid leukemia (AXIL) is the occurrence of...